NasdaqCM - Delayed Quote USD

PaxMedica, Inc. (PXMD)

0.7398 +0.0356 (+5.06%)
At close: April 26 at 4:00 PM EDT
0.7300 -0.01 (-1.32%)
After hours: April 26 at 7:57 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
16,145.2710
16,145.2710
10,604.4280
7,197.8000
5,565.8460
Operating Income
-16,145.2710
-16,145.2710
-10,604.4280
-7,197.8000
-5,565.8460
Net Non Operating Interest Income Expense
-9.1650
-9.1650
-396.4830
-2,805.8560
-662.9990
Other Income Expense
-2,135.2890
-2,135.2890
-3,800.8560
-225.3150
-1,597.1630
Pretax Income
-18,289.7250
-18,289.7250
-14,801.7670
-10,228.9710
-7,826.0080
Net Income Common Stockholders
-18,289.7250
-18,289.7250
-14,801.7670
-10,228.9710
-9,297.8720
Diluted NI Available to Com Stockholders
-18,289.7250
-18,289.7250
-14,801.7670
-10,228.9710
-9,297.8720
Basic EPS
-11.00
-11.00
-28.79
-26.01
-15.78
Diluted EPS
-11.00
-11.00
-28.79
-26.01
-15.78
Basic Average Shares
1,662.7950
1,662.7950
514.2160
392.1170
589.1980
Diluted Average Shares
1,662.7950
1,662.7950
514.2160
392.1170
589.1980
Total Operating Income as Reported
-16,145.2710
-16,145.2710
-10,604.4280
-7,197.8000
-5,565.8460
Total Expenses
16,145.2710
16,145.2710
10,604.4280
7,197.8000
5,565.8460
Net Income from Continuing & Discontinued Operation
-18,289.7250
-18,289.7250
-14,801.7670
-10,228.9710
-7,826.0080
Normalized Income
-18,244.1400
-18,244.1400
-16,513.3960
-9,830.3030
-6,228.8450
Interest Expense
9.1650
9.1650
5.2370
2,805.8560
609.4580
Net Interest Income
-9.1650
-9.1650
-396.4830
-2,805.8560
-662.9990
EBIT
-18,280.5600
-18,280.5600
-14,796.5300
-7,423.1150
-7,216.5500
EBITDA
-18,280.5600
-18,280.5600
-14,796.5300
-7,423.1150
-7,216.5500
Net Income from Continuing Operation Net Minority Interest
-18,289.7250
-18,289.7250
-14,801.7670
-10,228.9710
-7,826.0080
Total Unusual Items Excluding Goodwill
-45.5850
-45.5850
1,711.6290
-398.6680
-1,597.1630
Total Unusual Items
-45.5850
-45.5850
1,711.6290
-398.6680
-1,597.1630
Normalized EBITDA
-18,234.9750
-18,234.9750
-16,508.1590
-7,024.4470
-5,619.3870
12/31/2020 - 8/26/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SPRC SciSparc Ltd.
1.3200
+4.76%
 
CDIO Cardio Diagnostics Holdings, Inc.
0.6900
-4.49%
 
ZVSA ZyVersa Therapeutics, Inc.
4.9900
-16.83%
 
ALLR Allarity Therapeutics, Inc.
1.4600
+2.10%
 
VRAX Virax Biolabs Group Limited
0.6900
-1.71%
 
LGVN Longeveron Inc.
1.7500
+4.79%
 
PALI Palisade Bio, Inc.
6.05
-2.89%
 
ADIL Adial Pharmaceuticals, Inc.
1.6100
-6.94%
 
KTRA Kintara Therapeutics, Inc.
0.1488
-5.82%
 
NKGN NKGen Biotech, Inc.
1.6100
-18.69%